F-star Therapeutics Company
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
Industry:
PharmTech
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Employees Number:
51-100
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership